Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity was posted on September 16, 2014. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Q--Procurement of Blood Components (508-15-1-2065-0001)

Awarded
VA24714Q1660Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991
Federal
Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.
Solicitation # 0012468284
The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.
W40M MRC0 West

POSTED

10 days ago

DEADLINE

in 1 day
NAICS: 621991
Federal
6505--Human Blood and Blood Products
Solicitation # 36C25727Q0049
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.
257-NETWORK Contract Office 17 (36C257)

POSTED

14 days ago

DEADLINE

in 7 days
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

15 days ago

DEADLINE

in 3 months
NAICS: 621991
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

15 days ago

DEADLINE

in 4 months
NAICS: 621991
SLED
Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.
HOUSTON-GALVESTON AREA COUNCIL

POSTED

3 months ago

DEADLINE

in 9 months

AI Contract Overview

Show more

This firm-fixed-price contract establishes an agreement for the procurement and delivery of blood components to the Department of Veterans Affairs Medical Center Blood Bank in Decatur, Georgia. The contractor is responsible for providing approximately 400 units of Fresh Frozen Plasma, 30 units of Apheresis Platelets, and 10 units of Pre-pooled Cryoprecipitate on an as-needed basis. The period of performance begins October 1, 2014, and runs through September 30, 2015, with two additional option years. All deliverables must adhere to strict FDA and AABB standards, including comprehensive testing for various viruses and bacteria. The contractor must utilize validated shipping containers to maintain specific temperature requirements, specifically 20 to 24 degrees Celsius for platelets and -18 degrees Celsius or colder for frozen components. The agreement further stipulates that all project materials remain government property and that any changes to the scope of work must be approved in writing by the Contracting Officer.

General Info

Agency

N/A

Contract Value

$174,626.58

NAICS

621991 - Blood and Organ Banks

Place of Performance

Atlanta VA Medical Center;1670 Clairmont Road;Decatur, GA 30033-6137 US

Set-Aside

SBA

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Combined Synopsis

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
ContactsNo contacts available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
STATEMENT OF WORK A. GENERAL INFORMATION 1. Title of Project: Procurement of Platelets, Fresh Frozen Plasma, and Pre-Pooled Cryoprecipitate. 2. Scope of Work: The contractor shall provide all resources necessary to accomplish the deliverables described in this statement of work (SOW), except as may otherwise be specified. Contractor located at 4891 Ashford Dunwoody Road, Atlanta, GA 30338 shall deliver the following items to the Department of Veterans Affairs (VA) Medical Center Blood Bank Department located in Room 2B-168 at 1670 Clairmont Road, Decatur, GA 30033 in shipping containers that have been validated and meet Food and Drug Administration (FDA) and American Association of Blood Banks (AABB) temperature requirements in such quantities and at such times as may be required to support the hospital's transfusion needs: a. Approximately 400 units of Fresh Frozen Plasma b. Approximately 30 units of Apheresis Platelets c. Approximately 10 Pre-pooled Cryoprecipitate The exact number of products required will be predicated on transfusion requirements of Oncology, Surgery, Intensive Care, and the general wards. 3. Period of Performance: Base: 1 October 2014 through 30 September 2015 and 2 Option Years. 4. Type of Contract: Firm-Fixed-Price B. CONTRACT AWARD MEETING The contractor shall not commence performance on the tasks in this SOW until the CO has conducted a kick off meeting, or has advised the contractor that a kick off meeting is waived. C. GENERAL REQUIREMENTS 1. Contractor will supply all necessary containers for. These containers shall be validated by the vendor to ensure proper transport temperature is maintained per Food and Drug Administration (FDA) and American Association of Blood Banks (AABB) requirements. 2. Contractor may limit shipments whenever blood shortages preclude them from providing the requested volumes, and VAMC Atlanta may at times make adjustments to the number of units being requested. 3. All blood components shall be tested for Hepatitis B, Hepatitis C, Human Immunodeficiency Virus 1 and 2, Human T-cell Lymphotropic Viruses, Type 1 and 2, West Nile Virus, all species of bacteria, syphilis, and T. cruzi as required by the Food and Drug Administration (FDA) and the American Association of Blood Banks (AABB) and found lacking these markers and acceptable for patients at the VAMC Atlanta, GA. 4. It is the responsibility of the contractor's personnel to park in the appropriate designated parking areas. Parking information and building entry shall be coordinated with each facility COR. 5. The Atlanta VAMC does not validate parking nor is the facility responsible for parking violations. D. SPECIFIC MANDATORY TASKS AND ASSOCIATED DELIVERABLES Description of Tasks and Associated Deliverables: The contractor shall provide the specific deliverables described below within the performance period stated in Section A.4 of this SOW. The vendor shall provide the aforementioned blood components on an as needed basis beginning 1 October 2014. E. SCHEDULE FOR DELIVERABLES 1. The vendor shall provide blood components on an as needed schedule beginning 1 October 2014 and will work in conjunction with the COR to determine the delivery dates that best support VAMC Atlanta's transfusion demands. 2. If for any reason any deliverable cannot be delivered within the scheduled time frame, the contractor is required to contact Blood Bank personnel with information pertaining to the delay. If appropriate, the vendor will explain the circumstances surrounding the delay in writing to the CO, including a firm commitment of when the work shall be completed. F. CHANGES TO STATEMENT OF WORK Any changes to this SOW shall be authorized and approved only through written correspondence from the CO. A copy of each change will be kept in a project folder along with all other products of the project. Costs incurred by the contractor through the actions of parties other than the CO shall be borne by the contractor. G. TRAVEL [If applicable] Non-applicable H. GOVERNMENT RESPONSIBILITIES [If applicable] The government will ensure payment of properly prepared invoices on a monthly basis. Payments will be made in arrears. I. CONTRACTOR EXPERIENCE REQUIREMENTS Non-applicable J. CONFIDENTIALITY AND NONDISCLOSURE It is agreed that: 1. The preliminary and final deliverables, and all associated working papers, application source code, and other material deemed relevant by VA which have been generated by the contractor in the performance of this task order, are the exclusive property of the U.S. Government and shall be submitted to the CO at the conclusion of the task order. 2. The CO will be the sole authorized official to release, verbally or in writing, any data, draft deliverables, final deliverables, or any other written or printed materials pertaining to this task order. No information shall be released by the contractor. Any request for information relating to this task order, presented to the contractor, shall be submitted to the CO for response. 3. Press releases, marketing material, or any other printed or electronic documentation related to this project, shall not be publicized without the written approval of the CO. K. CONTRACTOR PERSONNEL SECURITY REQUIREMENTS Representatives and delivery personnel will not require access to VAMC Atlanta's computer systems or patient information to carry out the tasks outlined in this Statement of Work. Representatives/delivery personnel may however work in the vicinity of patient reports and will be escorted and monitored by Laboratory technologists throughout the entirety of their visit. L. SALIENT CHARACTERSITICS All blood components shall be tested for Hepatitis B, Hepatitis C, Human Immunodeficiency Virus 1 and 2, Human T-cell Lymphotropic Viruses, Type 1 and 2, West Nile Virus, all species of bacteria, syphilis, and T. cruzi as required by the Food and Drug Administration (FDA) and the American Association of Blood Banks (AABB) and found lacking these markers. Transport containers must be validated by the vendor and shown capable of maintaining proper shipping temperatures of 20 to 24 degrees C for platelets and -18 degrees C or colder for frozen components. M. DESCRIPTION and COSTS ITEM DESCRIPTION PRODUCT CODE UNIT OF ISSUE ESTIMATED UNIT COST 1. Fresh Frozen Plasma N/A EA 2. Apheresis Platelets N/A EA 3. Pre-Pooled Cryoprecipitate N/A EA N. REQUIRED APPENDEX:

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS